Type-1 Diabetes Treatment Market Analysis
According to Market Research Future (MRFR), the global type-1 diabetes treatment market is expected to cross USD 9.6 billion, with a CAGR of 7.9%. from 2019 to 2025 (forecast period).
Diabetes refers to a category of metabolic diseases characterized by high blood sugar levels. Diabetes is caused by inadequate secretion of insulin within the pancreas. Some of the common symptoms of diabetes are frequent urination, excessive thirst, increased appetite, weight loss, and tiredness. Type 1, type 2 diabetes, and gestational diabetes are three types of diabetes. Type 1 is a multifactorial chronic and autoimmune condition in which the body produces little or no insulin in the pancreas.
Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/sample_request/8199
The body requires insulin hormone to get glucose from the bloodstream to the cells to generate energy. Most forms of diabetes can be categorized as type 1a – Autoimmune disease, where the breakdown of pancreatic beta cells is observed, low insulin production disrupts blood glucose homeostasis, and mild cases of type 1b – Idiopathic Diabetes Mellitus. This type of diabetes is rare and occurs during childhood or adolescence, but can also be seen in adults.
Type-1 Diabetes Treatment Market Dynamics
The global market for type 1 diabetes is expected to grow significantly over the forecast period due to the rising prevalence of type-1 diabetes due to environmental and genetic factors. Unhealthy eating habits, growing geriatric population, increasing obesity, and sedentary lifestyles are the main contributors to the growth of the global type 1 diabetes industry. Governmental initiatives to control diabetes and the economic impact of the disease on health systems in several countries are expected to propel the market growth.
Whereas, intense reimbursement policies, adverse side effects of the medication, and high diagnosis and treatment costs are constraining factors for the growth of the global type 1 diabetes treatment market.
Type-1 Diabetes Treatment Market Segmentation
The global type-1 diabetes treatment market has been segmented into product and end-user.
Based on the product, the global market for type-1 diabetes treatment has been segmented into rapid-acting insulin, short-acting insulin, medium-acting insulin, long-acting insulin, and others. Rapid-acting insulin is the largest and fastest-growing market in this segment. The segment has been further divided into Admelog, Humalog, Novolog, and others. Short-acting insulin is effective for 3–6 hours. Medium-acting insulin is effective for 12–18 hours. Long-acting insulin is used for chronic cases and is effective for upwards of 24 hours. The segment has been further divided into Lantus, Levemir, and others. The segment for others includes ultra-long-term action insulin and inhaled insulin.
Based on end-user, the global market for type-1 diabetes treatment has been segmented into hospitals and clinics, specialty centers, and others. Hospitals and clinics segment is expected to be the largest and fastest-growing market during the forecast period. Specialty Centers segment is catering exclusively to patients who have diabetes; these centers are being opened across the globe. The segment for others includes treatment at home and old age homes.
Type-1 Diabetes Treatment Market Regional Analysis
Regionally, the global type-1 diabetes treatment market has been segmented into five major segments, including the Americas, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Americas to dominate the global market for type 1 diabetes treatment due to the growing incidence of diabetes in the region. The U.S. is developing as a power market with a large number of children under 14 years of age who have type 1 diabetes relative to other countries in the region.
The Asia Pacific is expected to record a significant growth rate over the forecast period due to an increase in the region’s aging population, with India emerging as a potential market leader over the forecast period.
Type-1 Diabetes Treatment Market Key Players
Some of the leading participants in the global type-1 diabetes treatment market are Astellas Pharma (Japan),Novartis (Switzerland), Merck (US), Novo Nordisk (Denmark), Sanofi (France), Boehringer Ingelheim GmbH (Germany), AstraZeneca (UK), Abbott Laboratories (US), Mannkind Corporation (US), Novartis (Switzerland), Braun Melsungen AG (Germany), Macrogenics, Inc. (US), Pfizer Inc. (US), DiaVacs, Inc. (US), Biodel, Inc. (US).
Table Of Contents
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.2 Scope Of The Study
2.2.1 Research Objective
Chapter 3. Research Methodology
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
Chapter 5. Market Factor Analysis
Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/type-1-diabetes-treatment-market-8199
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Market Research Future
+1 646 845 9312
NOTE: Our team of researchers are studying Covid-19 and its impact on various industry verticals and wherever required we will be considering covid-19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.